Market: China's biopharmaceutical industry maintains rapid growth

According to the "2009 China Biotechnology Development Report" published by the Ministry of Science and Technology on October 19, the output value of China's bio-industries has maintained rapid growth. The pharmaceutical manufacturing industry has increased by 21% year-on-year, 11.67% higher than that of the industrial and high-tech manufacturing industries. 15.86 percentage points.

From 2006 to 2009, the “Eleventh Five-Year Plan” and “863” Plan biopharmaceuticals have made major breakthroughs in several frontier technology fields. By the end of 2009, a total of 7 new drug certificates have been obtained in the field, and another 5 products are currently applying for new drug certificates, and 50 clinical approvals have been obtained, including 9 in phase III clinical and 23 in phase II clinical. 21 medical device certificates were obtained, and another 16 products were registered. A total of 14 new diagnostic kit product approvals were obtained, and another 7 products were under registration. It applied for 2,396 patents of various types, of which 2,166 were invention patents; 702 were granted various types of patents, of which 555 were invention patents, accounting for 79.1% of the total number of granted patents. A total of 44 results were transferred and the transfer revenue of the results was 181.13 million yuan; the new output value was about 5.87 billion yuan.

The report also shows that while maintaining a good momentum of rapid development, the biopharmaceutical industry structure has become increasingly clear. There are active mergers and acquisitions within the industry, and an oversized pharmaceutical enterprise group with a complete manufacturing and commercial industry chain has emerged. For instance, the Shenyang Qipanshan Development Zone Management Committee signed eight cooperation project agreements with the Shanghai Xinshengyuan Pharmaceutical Group and the Academy of Military Medical Sciences. According to the person in charge of the management committee, high-quality biological materials and medical devices will help improve the quality of human life. In the future, the region will focus on research and development of biological materials and medical devices, such as pacemakers, artificial kidneys, artificial bones, and artificial Joints and so on.